Societe Generale’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Societe Generale’s Portfolio SRGA Stock Details SRGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$330K	Buy	+3,060	New	+$358K	﹤0.01%	1904

Other funds holding SRGA

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Glen Capital Partners Waltham, Massachusetts $68.9M AUM 21.81% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Hillman Company Pittsburgh, Pennsylvania $257M AUM 26.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return

Societe Generale's SRGA Position: Q2 2016 in Review

Societe Generale opened a new position in Surgalign Holdings, Inc. Common Stock (SRGA) in Q2 2016: 3,060 shares worth $330K. The stake represents ﹤0.01% of the portfolio and ranks #1904 among its holdings.

111 funds tracked by Wall St. Rank hold SRGA as of Q2 2016.

Societe Generale held 3,060 shares of Surgalign Holdings, Inc. Common Stock worth $330K as of Q2 2016.
Surgalign Holdings, Inc. Common Stock was a new Societe Generale position in Q2 2016.
Surgalign Holdings, Inc. Common Stock made up ﹤0.01% of Societe Generale's portfolio in Q2 2016, its #1904 holding.
111 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q2 2016.

Based on Societe Generale's 13F filing for Q2 2016, filed 2 Aug 2016.